The Global Market for Pain Management Drugs and Devices

Report Highlights

The market for pain management drugs and devices was valued at $35.4 billion in 2012. Total market valued is expected to reach $41.5 billion in 2017 after increasing at a five-year compound annual growth rate of 3.2%.

Report Includes

• An overview of the global market for pain management drugs, which will address acute vs. chronic pain, treatments, and issues facing healthcare workers.
• Analyses of global market trends, with data from 2012, and projections of compound annual growth rates (CAGRs) through 2017.
• Examination of product categories, use of products, and the competitive landscape.
• Coverage of several significant market trends, including undertreatment issues, professional issues, managed care pain issues, trends in new therapies, product pipelines, generic participation, pain research, drug delivery, and patent expirations.
• Discussion of new regulatory requirements.
• Comprehensive company profiles of major players in the industry.

SCOPE AND FORMAT

This BCC Research report is designed to be a helpful business tool that will provide a thorough evaluation of the markets for pain management.  The geographical scope of this study is global with a U.S. emphasis.  This study will address acute versus chronic pain, treatments, and regulatory issues facing healthcare workers.  Also provided is detailed information based on product categories, use of products, forecasts, and competitive analyses.

The report identifies two general segments of pain management:

• Pharmaceuticals.
• Devices.

Within the pharmaceuticals segment several sub-segments are discussed in detail including:

• Narcotic pain management.
• Non-narcotic pain management.
• Antimigraine treatments.
• Anesthetics.
• Other drugs (including fibromyalgia treatments).

The device segment covers several product lines and specifically targets the largest product segments including:

• TENS and neuromuscular stimulators.
• Spinal cord stimulators.
• Other products (including electromagnetic therapies and other treatments).

Each market segment provides detailed information based on product categories, product use, forecasts, and competitive analyses.

Analyst Credentials

Melissa Elder is an experienced healthcare market analyst specializing in medical treatments, equipment and devices. Ms. Elder holds an MBA in Health Care Management and provides consultation to various institutions globally. She has been involved in the healthcare industry since 1996, providing more than 23 years of industry expertise. Ms. Elder has specialized in market research for more than 20 years, focusing on the areas of advanced medical technologies, biological products and animal health. In-depth analysis into more than 100 health-related topics has given Ms. Elder substantial insight into industry dynamics, market influences and future direction of various health markets. Her work in the medical community, including emergency room medical training and healthcare information system coordination, has enhanced her ability to provide insight into many healthcare specialties. She has authored several industry-specific documents and is a well-respected contributor to the market research community. Her writings are published in magazines, newspapers and professional journals. She is also an experienced custom market research writer who has worked with a large variety of clients in many fields who require innumerable variations to research documents.